{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/5f61e5b80af9f547701a9bd7/61addbbcd1502f0012c1c7f4?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"What is needed from the EMA to be better prepared for future health threats?","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/5f61e5b80af9f547701a9bd7/1600271043042-bde2222583277460ee436997b0538560.jpeg?height=200","description":"<p>Welcome to 19 Conversations. Today we're asking Michel Stoffel, Senior Adviser Global Regulatory Affairs, GSK and Isabelle Bekeredjian-Ding, Head of Microbiology Division, Paul-Ehrlich-Institut \"What is needed from the EMA to be better prepared for future health threats?\". Listen to hear their discussion on the challenge and how we're preparing for the future.</p>","author_name":"EFPIA"}